| Biotechnology Industry | Healthcare Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | 23 Oct 2009 Last Split | - IPO Date |
Aminologics Co., Ltd. is a forefront biotechnology company based in South Korea, dedicated to the development and production of innovative healthcare solutions. The essence of its operations lies within the biotechnology and pharmaceutical sectors, where it contributes significantly to the advancement of diagnostics and medical treatments. By focusing on creating advanced therapeutic products, Aminologics stands as a pivotal player in the healthcare industry, striving to solve critical health issues and elevate the quality of patient care. This commitment positions Aminologics within a global network of healthcare innovators, relentlessly pushing the boundaries of medical science and technology to improve health outcomes and the quality of life for people worldwide.
Aminologics Co., Ltd. offers a diverse range of products and services geared towards enhancing healthcare through innovation: